Canada Latent Tuberculosis Infection Detection Market Size, Share & Trends Analysis Report By Test Type (Tuberculin Skin Test, Interferon Gamma Release Assays), By End-use, By Province, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Market Segmentation and Scope
                       1.1.1 Segment Difinitions
                            1.1.1.1 Test Type Segment
                            1.1.1.2 End-use Segment
                   1.2 Regional Scope
                   1.3 Estimates and Forecast Timeline
                   1.4 Objectives
                       1.4.1 Objective - 1
                       1.4.2 Objective - 2
                       1.4.3 Objective - 3
                   1.5 Research Methodology
                   1.6 Information Procurement
                       1.6.1 Purchased Database
                       1.6.2 GVR’S Internal Database
                       1.6.3 Secondary Sources
                       1.6.4 Primary Research
                   1.7 Information or Data Analysis
                       1.7.1 Data Analysis Models
                   1.8 Market Formulation & Validation
                   1.9 Model Details
                       1.9.1 Commodity Flow Analysis
                   1.10 List of Secondary Sources
                   1.11 List of Abbreviations
Chapter 2 Executive Summary
                   2.1 Market Outlook
                   2.2 Segment Snapshot
                   2.3 Competitive Landscape
Chapter 3 Canada Latent Tuberculosis Infection Detection Market Variables, Trends & Scope
                   3.1 Canada Latent Tuberculosis Infection Detection Market Lineage Outlook
                       3.1.1 Parent market outlook
                       3.1.2 Ancillary market
                   3.2 Penetration & Growth Prospect Mapping for Test Type
                   3.3 Market Dynamics
                       3.3.1 Market driver analysis
                            3.3.1.1 High migration rate in Canada
                            3.3.1.2 Increasing demand for tuberculosis testing
                            3.3.1.3 Government initiatives to control tuberculosis
                       3.3.2 Market restraint analysis
                            3.3.2.1 Lack of systematic approach to screen tuberculosis
                            3.3.2.2 Lack of proper recommendations and reimbursement policies
                   3.4 Regulatory & Reimbursement Scenario
                   3.5 Canada Latent Tuberculosis Infection Market Analysis Tools
                       3.5.1 Porter’s Five Forces Analysis
                       3.5.2 SWOT Analysis; By factor (Political & Legal, Economic, and Technological)
                   3.6 Prevalence Rate of Latent Tuberculosis Infection, by Province (2018 - 2030) (in Thousands)
                   3.7 Incidence Rate of Latent Tuberculosis Infection, by Province (2018 - 2030) (in Thousands)
                   3.8 Estimated Number of Active TB Patients, by Province (2018 - 2022)
                   3.9 Estimated Number of LTBI Patients, by Province (2018 - 2022)
                   3.10 Wholesaler’s Cost for the following Tests (2022)
Chapter 4 Canada Latent Tuberculosis Infection Detection Market: Segment Analysis, By Test Type, 2018 - 2030 (USD Million) (Volume, Number of Tests)
                   4.1 Canada Latent Tuberculosis Infection Detection Market: Test Type Movement Analysis
                   4.2 Segment Dashboard
                       4.2.1 Tuberculin Skin Test (TST)
                            4.2.1.1 TST market estimates and forecast, 2018 - 2030 (USD Million)
                            4.2.1.2 TST market estimates and forecast, 2018 - 2030 Number of Tests in Thousands
                       4.2.2 Interferon Gamma Release Assays (IGRA)
                            4.2.2.1 IGRA market estimates and forecast, 2018 - 2030 (USD Million)
                            4.2.2.2 IGRA market estimates and forecast, 2018 - 2030 Number of Tests in Thousands
Chapter 5 Canada Latent Tuberculosis Infection Detection Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)
                   5.1 Canada Latent Tuberculosis Infection Detection Market: End Use Movement Analysis
                   5.2 Segment Dashboard
                       5.2.1 Diagnostic Laboratories
                            5.2.1.1 Diagnostic laboratories market estimates and forecast, 2018 - 2030 (USD Million)
                       5.2.2 Hospitals & Clinics
                            5.2.2.1 Hospitals & clinics market estimates and forecast, 2018 - 2030 (USD Million)
                       5.2.3 Academic & Research Institutions
                            5.2.3.1 Academic & research institutions market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6 Canada Latent Tuberculosis Infection Detection Market: Segment Analysis, By Province, 2018 - 2030 (USD Million)
                   6.1 Regional Market Share Analysis, 2022 & 2030
                   6.2 Canada
                       6.2.1 Canada Market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Tests)
                       6.2.2 Alberta
                            6.2.2.1 Alberta market estimates and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Tests)
                            6.2.2.2 Disease Prevalence
                            6.2.2.3 Regulatory Framework
                       6.2.3 British Columbia
                            6.2.3.1 British Columbia market estimates and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Tests)
                            6.2.3.2 Disease Prevalence
                            6.2.3.3 Regulatory Framework
                       6.2.4 Manitoba
                            6.2.4.1 Manitoba market estimates and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Tests)
                            6.2.4.2 Disease Prevalence
                            6.2.4.3 Regulatory Framework
                       6.2.5 New Brunswick
                            6.2.5.1 New Brunswick market estimates and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Tests)
                            6.2.5.2 Disease Prevalence
                            6.2.5.3 Regulatory Framework
                       6.2.6 Nova Scotia
                            6.2.6.1 Nova Scotia market estimates and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Tests)
                            6.2.6.2 Disease Prevalence
                            6.2.6.3 Regulatory Framework
                       6.2.7 Ontario
                            6.2.7.1 Ontario market estimates and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Tests)
                            6.2.7.2 Disease Prevalence
                            6.2.7.3 Regulatory Framework
                       6.2.8 Prince Edward Island
                            6.2.8.1 Prince Edward Island market estimates and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Tests)
                            6.2.8.2 Disease Prevalence
                            6.2.8.3 Regulatory Framework
                       6.2.9 Quebec
                            6.2.9.1 Quebec market estimates and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Tests)
                            6.2.9.2 Disease Prevalence
                            6.2.9.3 Regulatory Framework
                       6.2.10 Saskatchewan
                            6.2.10.1 Saskatchewan market estimates and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Tests)
                            6.2.10.2 Disease Prevalence
                            6.2.10.3 Regulatory Framework
                       6.2.11 Nunavut
                            6.2.11.1 Nunavut market estimates and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Tests)
                            6.2.11.2 Disease Prevalence
                            6.2.11.3 Regulatory Framework
                       6.2.12 Northwest Territories
                            6.2.12.1 Northwest Territories market estimates and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Tests)
                            6.2.12.2 Disease Prevalence
                            6.2.12.3 Regulatory Framework
                       6.2.13 Yukon
                            6.2.13.1 Yukon market estimates and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Tests)
                            6.2.13.2 Disease Prevalence
                            6.2.13.3 Regulatory Framework
                       6.2.14 Newfoundland & Labrador
                            6.2.14.1 Newfoundland & Labrador market estimates and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Tests)
                            6.2.14.2 Disease Prevalence
                            6.2.14.3 Regulatory Framework
Chapter 7 Canada Latent Tuberculosis Infection Detection Market - Competitive Analysis
                   7.1 Company Categorization
                   7.2 Strategy Mapping
                       7.2.1 New Product Launch
                       7.2.2 Megers & Acquisitions
                       7.2.3 Partnerships
                       7.2.4 Others
                   7.3 Key Company Market Share Analysis, 2022
                   7.4 Company Profiles
                       7.4.1 F. Hoffmann-La Roche Ltd.
                            7.4.1.1 Company overview
                            7.4.1.2 Financial performance
                            7.4.1.3 Product benchmarking
                            7.4.1.4 Strategic initiatives
                       7.4.2 Abbott
                            7.4.2.1 Company overview
                            7.4.2.2 Alere, Inc.
                            7.4.2.3 Financial performance
                            7.4.2.4 Product benchmarking
                            7.4.2.5 Strategic initiatives
                       7.4.3 QIAGEN
                            7.4.3.1 Company overview
                            7.4.3.2 Financial performance
                            7.4.3.3 Product benchmarking
                            7.4.3.4 Strategic initiatives
                       7.4.4 BD (Becton, Dickinson and Company)
                            7.4.4.1 Company overview
                            7.4.4.2 Financial performance
                            7.4.4.3 Product benchmarking
                            7.4.4.4 Strategic initiatives
                       7.4.5 BIOMÉRIEUX
                            7.4.5.1 Company overview
                            7.4.5.2 Financial performance
                            7.4.5.3 Product benchmarking
                            7.4.5.4 Strategic initiatives
                       7.4.6 Oxford Immunotec USA, Inc.
                            7.4.6.1 Company overview
                            7.4.6.2 Product benchmarking
                            7.4.6.3 Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Canada latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million)
Table 4 Canada latent tuberculosis infection detection market, by test type, 2018 - 2030 (Number of tests)
Table 5 Canada latent tuberculosis infection detection market, by end use, 2018 - 2030 (USD Million)
Table 6 Alberta latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million)
Table 7 Alberta latent tuberculosis infection detection market, by test type, 2018 - 2030 (Number of tests)
Table 8 Alberta latent tuberculosis infection detection market, by end use, 2018 - 2030 (USD Million)
Table 9 British Columbia latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million)
Table 10 British Columbia latent tuberculosis infection detection market, by test type, 2018 - 2030 (Number of tests)
Table 11 British Columbia latent tuberculosis infection detection market, by end use, 2018 - 2030 (USD Million)
Table 12 Manitoba latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million)
Table 13 Manitoba latent tuberculosis infection detection market, by test type, 2018 - 2030 (Number of tests)
Table 14 Manitoba latent tuberculosis infection detection market, by end use, 2018 - 2030 (USD Million)
Table 15 New Brunswick latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million)
Table 16 New Brunswick latent tuberculosis infection detection market, by test type, 2018 - 2030 (Number of tests)
Table 18 New Brunswick latent tuberculosis infection detection market, by end use, 2018 - 2030 (USD Million)
Table 18 Nova Scotia latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million)
Table 19 Nova Scotia latent tuberculosis infection detection market, by test type, 2018 - 2030 (Number of tests)
Table 20 Nova Scotia latent tuberculosis infection detection market, by end use, 2018 - 2030 (USD Million)
Table 21 Ontario latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million)
Table 22 Ontario latent tuberculosis infection detection market, by test type, 2018 - 2030 (Number of tests)
Table 23 Ontario latent tuberculosis infection detection market, by end use, 2018 - 2030 (USD Million)
Table 24 Prince Edward Island latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million)
Table 25 Prince Edward Island latent tuberculosis infection detection market, by test type, 2018 - 2030 (Number of tests)
Table 26 Prince Edward Island latent tuberculosis infection detection market, by end use, 2018 - 2030 (USD Million)
Table 27 Quebec latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million)
Table 30 Quebec latent tuberculosis infection detection market, by test type, 2018 - 2030 (Number of tests)
Table 29 Quebec latent tuberculosis infection detection market, by end use, 2018 - 2030 (USD Million)
Table 30 Saskatchewan latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million)
Table 31 Saskatchewan latent tuberculosis infection detection market, by test type, 2018 - 2030 (Number of tests)
Table 32 Saskatchewan latent tuberculosis infection detection market, by end use, 2018 - 2030 (USD Million)
Table 33 Northwest Territories latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million)
Table 34 Northwest Territories latent tuberculosis infection detection market, by test type, 2018 - 2030 (Number of tests)
Table 35 Northwest Territories latent tuberculosis infection detection market, by end use, 2018 - 2030 (USD Million)
Table 36 Nunavut latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million)
Table 37 Nunavut latent tuberculosis infection detection market, by test type, 2018 - 2030 (Number of tests)
Table 38 Nunavut latent tuberculosis infection detection market, by end use, 2018 - 2030 (USD Million)
Table 39 Yukon latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million)
Table 40 Yukon latent tuberculosis infection detection market, by test type, 2018 - 2030 (Number of tests)
Table 41 Yukon latent tuberculosis infection detection market, by end use, 2018 - 2030 (USD Million)
Table 42 Newfoundland & Labrador latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million)
Table 43 Newfoundland & Labrador latent tuberculosis infection detection market, by test type, 2018 - 2030 (Number of tests)
Table 44 Newfoundland & Labrador latent tuberculosis infection detection market, by end use, 2018 - 2030 (USD Million)
Table 45 Leading market players anticipated to witness highest growth

List of Figures

Fig. 1 Canada latent tuberculosis infection detection market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Canada latent tuberculosis infection detection market outlook (2022)
Fig. 10 Penetration & growth prospect mapping, test type
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Porter’s five forces analysis
Fig. 14 SWOT analysis
Fig. 15 Canada latent tuberculosis infection detection market: Test type outlook and key takeaways
Fig. 16 Canada latent tuberculosis infection detection market: Test type movement analysis
Fig. 18 Canada latent tuberculosis infection detection market: Test type segment dashboard
Fig. 18 Tuberculin skin test market estimates and forecast, 2018 - 2030 ((USD Million))
Fig. 19 Tuberculin skin test market estimates and forecast, 2018 - 2030 (tests in thousands)
Fig. 20 Interferon-gamma release assays market estimates and forecast, 2018 - 2030 ((USD Million))
Fig. 21 Interferon-gamma release assays market estimates and forecast, 2018 - 2030 (tests in thousands)
Fig. 22 Canada latent tuberculosis infection detection market: End use outlook and key takeaways
Fig. 23 Canada latent tuberculosis infection detection market: End use movement analysis
Fig. 24 Canada latent tuberculosis infection detection market: End use segment dashboard
Fig. 25 Diagnostic laboratories market estimates and forecast, 2018 - 2030 ((USD Million))
Fig. 26 Hospitals & clinics market estimates and forecast, 2018 - 2030 ((USD Million))
Fig. 27 Academic & research institutions market estimates and forecast, 2018 - 2030 ((USD Million))
Fig. 30 Canada
Fig. 29 Canada market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Alberta
Fig. 31 Alberta market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 British Columbia
Fig. 33 British Columbia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Manitoba
Fig. 35 Manitoba market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 New Brunswick
Fig. 37 New Brunswick market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Nova Scotia
Fig. 39 Nova Scotia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Ontario
Fig. 41 Ontario market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Prince Edward Island
Fig. 43 Prince Edward Island market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Quebec
Fig. 45 Quebec market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Saskatchewan
Fig. 47 Saskatchewan market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Nunavut
Fig. 49 Nunavut market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Northwest Territories
Fig. 51 Northwest Territories market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Yukon
Fig. 53 Yukon market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Newfoundland & Labrador
Fig. 55 Newfoundland & Labrador market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Strategy framework
Fig. 57 Participant categorization
Fig. 58 Ansoff matrix
Fig. 59 Company market position analysis
Fig. 60 Company market position analysis
Fig. 61 Market differentiators